Y-Intercept (HK)’s Emergent Biosolutions EBS Stock Holding History

Y-Intercept (HK)’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39M	Buy	+165,879	New	+$1.39M	0.03%	892
2026 Q1	–	Sell	-14,011	Closed	-$173K	–	1670
2025 Q4	$173K	Sell	14,011 -3,577	-20%	-$38.3K	﹤0.01%	1448
2025 Q3	$155K	Buy	+17,588	New	+$137K	﹤0.01%	1480
2025 Q2	–	Sell	-95,026	Closed	-$462K	–	1715
2025 Q1	$462K	Buy	+95,026	New	+$787K	0.03%	727
2024 Q3	–	Sell	-16,233	Closed	-$111K	–	1436
2024 Q2	$111K	Buy	+16,233	New	+$69.9K	0.01%	1251
2023 Q4	–	Sell	-75,362	Closed	-$256K	–	1330
2023 Q3	$256K	Buy	+75,362	New	+$418K	0.03%	826
2023 Q1	–	Sell	-24,009	Closed	-$284K	–	1259
2022 Q4	$284K	Buy	24,009 +8,831	+58%	+$137K	0.04%	685
2022 Q3	$319K	Buy	+15,178	New	+$422K	0.03%	684

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Y-Intercept (HK)'s EBS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 165,879 shares worth $1.39M. The stake represents 0.03% of the portfolio and ranks #892 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in EBS as recently as Q4 2025.

Y-Intercept (HK) first reported a position in EBS in Q3 2022 and has held it in 8 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Y-Intercept (HK) held 165,879 shares of Emergent Biosolutions worth $1.39M as of Q2 2026.
Emergent Biosolutions was a new Y-Intercept (HK) position in Q2 2026.
Emergent Biosolutions made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #892 holding.
Y-Intercept (HK) first reported a position in Emergent Biosolutions in Q3 2022 and has held it in 8 quarters since.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.